title: PTEN plasticity: how the taming of a lethal gene can go too far.
abstract: PTEN loss drives many cancers and recent genetic studies reveal that often PTEN is antagonised at the protein level without alteration of DNA or RNA expression. This scenario can already cause malignancy, because PTEN is haploinsufficient. We here review normally occurring mechanisms of PTEN protein regulation and discuss three processes where PTEN plasticity is needed: ischaemia, development, and wound healing. These situations demand transient PTEN suppression, whereas cancer exploits them for continuous proliferation and survival advantages. Therefore, increased understanding of PTEN plasticity may help us better interpret tumour development and ultimately lead to drug targets for PTEN supporting cancer therapy.
authors.affiliation: Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
authors.forename: Adam
authors.initials: A
authors.lastname: Naguib
authors.forename: Lloyd C
authors.initials: LC
authors.lastname: Trotman
mesh_terms: D002470:Cell Survival / Q000235:genetics; D005804:Genes, Lethal / Q000235:genetics*; D006801:Humans; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D009474:Neurons / Q000166:cytology; D051059:PTEN Phosphohydrolase / Q000235:genetics* / Q000378:metabolism; D014945:Wound Healing / Q000235:genetics
chemical_list: D051059:PTEN Phosphohydrolase
keywords: PTEN regulation; nerve regeneration; stroke; tumour suppressor